Nomura Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.8M Buy
50,500
+25,400
+101% +$8.35M 0.04% 328
2025
Q4
$8.8M Buy
25,100
+6,600
+36% +$2.23M 0.01% 574
2025
Q3
$5.98M Buy
18,500
+17,800
+2,543% +$5.54M 0.01% 700
2025
Q2
$272K Sell
700
-6,800
-91% -$2.74M ﹤0.01% 1258
2025
Q1
$3.26M Buy
+7,500
New +$3.01M 0.01% 863
2024
Q2
Sell
-30,000
Closed -$15.6M 1827
2024
Q1
$15.6M Buy
+30,000
New +$14.9M 0.04% 323
2021
Q4
Sell
-10,000
Closed -$3.76M 2304
2021
Q3
$3.76M Buy
+10,000
New +$3.8M 0.01% 724
2020
Q4
Sell
-500
Closed -$134K 1552
2020
Q3
$134K Sell
500
-282,500
-100% -$76M ﹤0.01% 1201
2020
Q2
$74.4M Buy
+283,000
New +$75.5M 0.26% 51
2016
Q4
Sell
-37,500
Closed -$4.7M 1569
2016
Q3
$4.7M Buy
+37,500
New +$4.84M 0.01% 444
2014
Q4
Sell
-9,200
Closed -$1.09M 2392
2014
Q3
$1.09M Buy
9,200
+200
+2% +$22.9K ﹤0.01% 1404
2014
Q2
$969K Buy
9,000
+5,900
+190% +$608K ﹤0.01% 1451
2014
Q1
$309K Buy
+3,100
New +$280K ﹤0.01% 2074

Other funds holding ELV

Nomura Holdings's ELV Position: Q1 2026 in Review

Nomura Holdings opened a new position in Elevance Health (ELV) in Q1 2026: 749 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #1558 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in ELV as recently as Q3 2025.

Nomura Holdings first reported a position in ELV in Q2 2013 and has held it in 45 quarters since. The position peaked at $63.8M in Q3 2020. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Nomura Holdings held 749 shares of Elevance Health worth $219K as of Q1 2026.
  • Elevance Health was a new Nomura Holdings position in Q1 2026.
  • Elevance Health made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1558 holding.
  • Nomura Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 45 quarters since.
  • Nomura Holdings's Elevance Health position peaked at $63.8M in Q3 2020.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.